First Choice Healthcare Solutions, Inc. (symbol: FCHS) is the issuer of record for a Form 8-K filing submitted to the SEC.
First Choice Healthcare Solutions, Inc. reported a very small operating platform and a heavily leveraged capital structure for the six months ended June 30, 2026. Total assets were $576,493 against total liabilities of $10,084,581, leaving a stockholders’ deficit of $9,508,087, improved from a $39,528,075 deficit at December 31, 2025, mainly due to large debt-for-equity conversions and lease/AP settlements.
Operations remain minimal: revenue for the first half of 2026 was $3,406, while operating expenses were about $1.27 million, producing an operating loss of $1,267,310. Net loss attributable to common shareholders expanded to $8,447,243 (loss per share $0.26) from $2,037,329 (loss per share $0.06) in the prior-year period, driven largely by $7,385,781 of interest expense tied to convertible and other debt and their conversion to preferred equity.
Liquidity is strained: cash was only $6,842 and the company had a working capital deficit, while all non-convertible and convertible notes are classified as current. Management discloses substantial doubt about the ability to continue as a going concern without additional capital or successful execution of its growth and acquisition strategy. After quarter-end, the company signed a Business Combination Agreement with Westin Acquisition Corp. and binding agreements to acquire several Pointe Med entities, aiming to build a broader healthcare platform.
First Choice Healthcare Solutions, Inc. entered into a Business Combination Agreement with Westin Acquisition Corp., a Nasdaq-listed SPAC, and a merger subsidiary to create a publicly traded healthcare and wellness company. Westin will first domesticate from the Cayman Islands to Nevada as “Wellgevity 360, Inc.” (“PubCo”), after which the merger subsidiary will merge into First Choice, leaving First Choice as a wholly owned subsidiary of PubCo.
The transaction implies a pre-money equity value of up to approximately $650 million for First Choice, payable in PubCo common stock based on an equity-value-to-redemption-price formula. Each share of First Choice common (and any preferred) stock, other than excluded or dissenting shares, will convert into PubCo shares, with Company equity awards handled under the agreement. Concurrently, First Choice signed agreements to acquire the Pointe Med Entities, expected to close substantially concurrently with the business combination, and secured a PIPE investment in PubCo preferred stock with an aggregate stated value of $12,500,000 for a $10,000,000 purchase price at closing.
Closing is subject to SEC effectiveness of a Form S-4 registration statement, Nasdaq listing approval for PubCo shares, required shareholder consents, absence of specified material adverse effects and regulatory issues, and substantially simultaneous completion of the Pointe Med acquisitions. The agreement includes customary termination rights, including if closing has not occurred by March 31, 2027 (subject to automatic extension to April 30, 2027 in certain SEC-review circumstances). Post-closing, PubCo’s initial board is expected to have five directors, a majority independent, with one designated by the SPAC sponsor and three plus the CEO designated by First Choice, alongside lock-up and registration rights arrangements for key holders.
First Choice Healthcare Solutions, Inc. is registering 12,863,000 shares of common stock tied to a new capital raise and related conversions. The company plans a best-efforts, all‑or‑none initial public offering of 3,800,000 shares of Series D Convertible Preferred Stock, each bundled with a warrant to buy one additional Series D preferred share, at an assumed combined price of $5 per unit.
The preferred shares carry a 9% cumulative annual dividend and convert to common stock at an assumed $5 per share, with matching $5 warrant exercise price and no conversion floor, creating meaningful potential dilution. Gross proceeds are shown as $19,000,000, with estimated net proceeds of $17,480,000 before expenses. A concurrent resale registration covers up to 3,000,010 common shares held by selling stockholders.
The structure is paired with a 1‑for‑2,000 reverse stock split of 32,958,288 existing common shares, while the newly issued IPO and specified private placement shares are exempt from the split. Proceeds are earmarked for acquisitions, building a national primary care and wellness clinic platform, pharmacy expansion, staffing, and general corporate purposes.
First Choice Healthcare Solutions, Inc. is registering 12,863,000 shares of common stock issuable from a best efforts offering of up to 3,800,000 shares of Series D Convertible Preferred Stock and matching Warrants, plus related dividend and anti-dilution shares. A concurrent Resale Prospectus covers up to 3,000,010 existing common shares.
The Series D Preferred carries a 9% cumulative dividend, converts at an assumed $5 price, and includes anti-dilution that can lower the conversion price with no floor, potentially increasing share issuance. Warrants to purchase up to 3,800,000 additional Series D Preferred shares are exercisable immediately at an assumed $5 price.
The company expects gross proceeds of $19,000,000 and approximately $17,080,000 in net proceeds, to fund acquisitions (including Pointe Med/LiveWell and The Good Clinic), staffing, working capital, and marketing as it pivots from legacy orthopedic services to a national network of nurse practitioner–led primary care and wellness clinics supported by in-house compounding pharmacy operations.
First Choice Healthcare Solutions, Inc. reports a challenging year while pursuing a major strategic pivot. For 2025 it recorded a net loss of approximately $7.1 million and operating cash outflows of about $0.55 million, bringing its accumulated deficit to roughly $74.7 million and total debt to $27.2 million.
The company emerged from Chapter 11 in 2022 and is shifting away from legacy orthopedic and physical therapy services toward a national network of functional health and wellness clinics centered on primary care, anti-aging, weight management, hormone therapy and a compounding pharmacy platform. Management plans multiple acquisitions, including primary-care clinics and compounding pharmacies, and aims to leverage nurse practitioners and centralized back-office systems to improve margins.
Auditors highlight substantial doubt about the company’s ability to continue as a going concern, citing continued losses, high indebtedness and the need for additional capital to execute the growth strategy. Success depends on closing planned acquisitions, scaling new clinics, managing significant regulatory and operational risks in compounding pharmacy and healthcare compliance, and rebuilding relationships after prior litigation and bankruptcy.
First Choice Healthcare Solutions, Inc. filed Amendment No. 12 to its S-1 registration statement, mainly to update the exhibit list in Item 16 while leaving the preliminary prospectus unchanged and therefore omitted.
The filing explains that the company is using both an IPO Prospectus and a Resale Prospectus. The Resale Prospectus removes capitalization, dilution and underwriting sections, adds a selling stockholder and plan of distribution section, and adjusts covers, use of proceeds and legal matters language. The company notes that IPO sales and any resale of registered common stock could occur sequentially or at the same time, which may affect the price, liquidity and demand for its shares.
First Choice Healthcare Solutions, Inc. is registering 12,863,000 shares of common stock tied to a new Series D Convertible Preferred Stock financing and related warrants. The firm commitment IPO covers up to 3,800,000 Series D preferred shares, each sold with a warrant to buy one additional Series D share, all initially priced around $5 for conversion and exercise.
The company expects gross proceeds of $19,000,000 and approximately $17,480,000 before expenses, with a 45‑day over‑allotment option for 570,000 additional preferred shares and/or warrants. A concurrent Resale Prospectus registers up to 3,000,010 common shares for selling stockholders, who will not deliver proceeds to the company.
First Choice is pivoting from legacy orthopedic and physical therapy services, which it plans to terminate, to a national chain of primary care and wellness clinics supported by an in‑house compounding pharmacy. The company has a long history of losses, emerged from bankruptcy in 2022, and plans to use IPO proceeds for acquisitions, staffing, working capital and marketing while highlighting significant dilution and anti‑dilution features that could increase common share issuance over time.